Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

NCT00889525 is registered in ClinicalTrials.gov with Seth Gordhandas Sunderdas Medical College as lead sponsor.

NCT NCT00889525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00889525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Lead sponsor
Seth Gordhandas Sunderdas Medical College
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2007
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corticotroph adenoma, cushing's disease